Case number 2022-2217
United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 20, 2024 | 77 | The petition for writ of certiorari, No. 23-504, filed on 01/23/2024, was Denied on 02/20/2024. [985256] [22-2217, 23-1021] [MVH] [Entered: 02/21/2024 10:44 AM] (1) |
| Jan 25, 2024 | 76 | Petition for writ of certiorari filed on 01/23/2024 in the U.S. Supreme Court. No.: 23-504, Inc. Liquidia Technologies v. United Therapeutics Corporation. [979707] [MVH] [Entered: 01/26/2024 03:31 PM] (1) |
| Dec 20, 2023 | 75 | Notice from the U.S. Supreme Court regarding The application for an extension of time within which to file a petition for a writ of certiorari is extended until 1/24/24. [973370] [MVH] [Entered: 12/28/2023 12:06 PM] (3) |
| Oct 3, 2023 | 74 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [954015] [22-2217, 23-1021] [MVH] [Entered: 10/03/2023 11:51 AM] (1) |
| Sep 26, 2023 | 73 | ORDER filed denying petition for panel rehearing and rehearing en banc [68] filed by United Therapeutics Corporation, denying petition for panel rehearing and rehearing en banc [65] filed by Liquidia Technologies, Inc. By: Per Curiam. Service as of this date by the Clerk of Court. [952402] [MVH] [Entered: 09/26/2023 10:05 AM] (2) |
| Sep 14, 2023 | 72 | **TEXT ONLY** ORDER granting Liquidia Technologies, Inc.'s motion [71] to withdraw counsel Deepa Kannappan. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [950106] [MJL] [Entered: 09/14/2023 03:59 PM] (0) |
| Sep 14, 2023 | 71 | MOTION of Appellant Liquidia Technologies, Inc. to withdraw counsel Deepa Kannappan. Service: 09/14/2023 by email. [950040] [22-2217] [Sanya Sukduang] [Entered: 09/14/2023 02:10 PM] (7) |
| Aug 25, 2023 | 70 | 13 paper copies of Doc. No. [65], received from Appellant Liquidia Technologies, Inc.. [946039] [VDW] [Entered: 08/25/2023 03:46 PM] (0) |
| Aug 25, 2023 | 69 | 13 paper copies of Doc. No. [68], received from Cross-Appellant United Therapeutics Corporation. [946029] [VDW] [Entered: 08/25/2023 03:41 PM] (0) |
| Aug 23, 2023 | 68 | Petition for panel rehearing, for en banc rehearing filed by Cross-Appellant United Therapeutics Corporation. Service: 08/23/2023 by email. [945455] [22-2217] [Jaime Santos] [Entered: 08/23/2023 06:59 PM] (51) |
| Aug 23, 2023 | 67 | Notice of Related Case Information for Appellant Liquidia Technologies, Inc.. Service: 08/23/2023 by email. [945413] [22-2217] [Sanya Sukduang] [Entered: 08/23/2023 04:49 PM] (3) |
| Aug 23, 2023 | 66 | Amended Certificate of Interest for Appellant Liquidia Technologies, Inc.. Service: 08/23/2023 by email. [945411] [22-2217] [Sanya Sukduang] [Entered: 08/23/2023 04:48 PM] (3) |
| Aug 23, 2023 | 65 | Petition for en banc hearing, for panel rehearing filed by Appellant Liquidia Technologies, Inc.. Service: 08/23/2023 by email. [945398] [22-2217] [Sanya Sukduang] [Entered: 08/23/2023 04:38 PM] (46) |
| Jul 30, 2023 | 0 | UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC. [OPINION] [precedential] (0) |
| Jul 26, 2023 | 64 | **TEXT ONLY** ORDER granting Liquidia Technologies, Inc.'s motion [63] to withdraw Erik Benton Milch as counsel. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [938488] [MJL] [Entered: 07/26/2023 09:25 AM] (0) |
| Jul 25, 2023 | 63 | MOTION of Appellant Liquidia Technologies, Inc. to withdraw counsel Erik Benton Milch. Service: 07/25/2023 by email. [938455] [22-2217] [Sanya Sukduang] [Entered: 07/25/2023 06:14 PM] (7) |
| Jul 24, 2023 | 62 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [937885] [22-2217, 23-1021] [MVH] [Entered: 07/24/2023 10:14 AM] (1) |
| Jul 24, 2023 | 61 | OPINION filed for the court by Lourie, Circuit Judge; Dyk, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [937880] [MVH] [Entered: 07/24/2023 10:11 AM] (23) |
| Jul 20, 2023 | 60 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [6], ERROR: The contact information included on the entry of appearance (EOA) on record for Erik Benton Milch does not match the information in the attorney's user account. CORRECTION: ursuant to FCR 47.3(c)(1), please update as needed to ensure the contact information on the EOA and in the user account matches. Account information may be updated at www.pacer.gov, or counsel may file an amended EOA, or a notice of withdrawal if appropriate. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [937419] [MVH] [Entered: 07/20/2023 03:35 PM] (0) |
| May 30, 2023 | 59 | RESPONSE of Cross-Appellant United Therapeutics Corporation to Doc No. [58]. Service: 05/30/2023 by email. [926533] [22-2217] [Jaime Santos] [Entered: 05/30/2023 01:47 PM] (2) |
| May 24, 2023 | 58 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Liquidia Technologies, Inc.. Service: 05/24/2023 by email. [925737] [22-2217] [Sanya Sukduang] [Entered: 05/24/2023 05:31 PM] (16) |
| May 3, 2023 | 57 | Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Dyk, Circuit Judge and Stoll, Circuit Judge.Arguing counsel: Mr. Sanya Sukduang for Liquidia Technologies, Inc. and Mr. William M. Jay for United Therapeutics Corporation.Oral Argument Audio available here. [920942] [JCP] [Entered: 05/03/2023 04:04 PM] (0) |
| Apr 6, 2023 | 56 | RESPONSE of Cross-Appellant United Therapeutics Corporation to Doc No. [33]. Service: 04/06/2023 by email. [915148] [22-2217] [Jaime Santos] [Entered: 04/06/2023 07:13 PM] (2) |
| Apr 4, 2023 | 55 | Response to notice of oral argument from Appellant Liquidia Technologies, Inc.. Service: 04/04/2023 by email. [914521] [22-2217] [Sanya Sukduang] [Entered: 04/04/2023 08:03 PM] (1) |
| Apr 4, 2023 | 54 | Response to notice of oral argument from Cross-Appellant United Therapeutics Corporation. Service: 04/04/2023 by email. [914519] [22-2217] [William Jay] [Entered: 04/04/2023 07:42 PM] (1) |
| Mar 21, 2023 | 53 | NOTICE OF ORAL ARGUMENT. Panel: 2305E. Case scheduled May 3, 2023. Response to Notice of Oral Argument due: 04/04/2023. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [911365] [MVH] [Entered: 03/21/2023 03:41 PM] (2) |
| Mar 13, 2023 | 49 | The following conflict dates submitted by William M. Jay for United Therapeutics Corporation have been accepted by the court: 06/05/2023, 06/07/2023, 07/14/2023, 08/07/2023. The following conflicts are not accepted at this time: 05/01/2023, 05/02/2023. [909588] [MJL] [Entered: 03/13/2023 04:01 PM] (0) |
| Mar 13, 2023 | 48 | The following conflict dates submitted by Sanya Sukduang for Liquidia Technologies, Inc. have been accepted by the court: 06/08/2023, 06/09/2023, 09/05/2023, 09/06/2023. The following conflict dates are not accepted at this time: 07/11/2023, 07/12/2023. [909587] [MJL] [Entered: 03/13/2023 04:00 PM] (0) |
| Mar 13, 2023 | 47 | Notice from Cross-Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 03/13/2023 by email. [909495] [22-2217] [William Jay] [Entered: 03/13/2023 01:33 PM] (3) |
| Mar 10, 2023 | 52 | 6 paper copies of Doc. Nos. [39], [41] received from Cross-Appellant United Therapeutics Corporation. [910284] [MJL] [Entered: 03/15/2023 04:45 PM] (0) |
| Mar 10, 2023 | 51 | 6 paper copies of Doc. No. [32] received from Appellant Liquidia Technologies, Inc. [910281] [MJL] [Entered: 03/15/2023 04:42 PM] (0) |
| Mar 10, 2023 | 50 | 6 paper copies of Doc. No. [42], [21] received from Appellant Liquidia Technologies, Inc.. [910196] [VDW] [Entered: 03/15/2023 03:03 PM] (0) |
| Mar 10, 2023 | 46 | Notice from Appellant Liquidia Technologies, Inc. regarding conflicts with oral argument. Service: 03/10/2023 by email. [909133] [22-2217] [Sanya Sukduang] [Entered: 03/10/2023 11:34 AM] (3) |
| Mar 8, 2023 | 45 | ORDER granting the motions [905200-2] [905203-2] filed by Appellant United Therapeutics Corporation. Appeal No. 2022-2133 is no longer designated a companion to Appeal Nos. 2022-2217 and 2023-1021. UTC's reply brief in Appeal No. 2022-2133 is due no later than March 30, 2023. Service as of this date by the Clerk of Court. [908613] [22-2133, 22-2217] [LMS] [Entered: 03/08/2023 02:51 PM] (3) |
| Mar 8, 2023 | 44 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [908586] [ALK] [Entered: 03/08/2023 01:59 PM] (0) |
| Mar 8, 2023 | 43 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [908585] [ALK] [Entered: 03/08/2023 01:56 PM] (1) |
| Feb 21, 2023 | 39 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Cross-Appellant United Therapeutics Corporation. Service: 02/21/2023 by email. [905361]--[Edited 03/07/2023 by ALK - compliance review complete] [Jaime Santos] [Entered: 02/21/2023 07:14 PM] (107) |
| Feb 21, 2023 | 37 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Cross-Appellant United Therapeutics Corporation. Service: 02/21/2023 by email. [905357] [22-2217] [Jaime Santos] [Entered: 02/21/2023 06:56 PM] (3) |
| Feb 21, 2023 | 38 | Notice of Correction to Doc No. [35], [36] for Cross-Appellant United Therapeutics Corporation. Service: 02/21/2023 by email. [905359] [22-2217] [Jaime Santos] [Entered: 02/21/2023 07:06 PM] (3) |
| Feb 21, 2023 | 40 | MODIFIED ENTRY: APPENDIX FILED by Appellant Liquidia Technologies, Inc. Service: 02/21/2023 by email. [905362] --[Edited 03/07/2023 by ALK - compliance review complete] [Sanya Sukduang] [Entered: 02/21/2023 07:16 PM] (1300) |
| Feb 21, 2023 | 41 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Cross-Appellant United Therapeutics Corporation. Service: 02/21/2023 by email. [905363]--[Edited 03/07/2023 by ALK - compliance review complete] [Jaime Santos] [Entered: 02/21/2023 07:21 PM] (45) |
| Feb 21, 2023 | 42 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant Liquidia Technologies, Inc. Service: 02/21/2023 by email. [905364]--[Edited 03/07/2023 by ALK - compliance review complete] [Sanya Sukduang] [Entered: 02/21/2023 07:22 PM] (0) |
| Feb 13, 2023 | 36 | MODIFIED ENTRY: REPLY BRIEF FILED by Cross-Appellant United Therapeutics Corporation. Service: 02/13/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [903891] --[Edited 02/21/2023 by ALK - compliance review complete] This document has been corrected. See Doc No. [41]. [Jaime Santos] [Entered: 02/13/2023 06:09 PM] (45) |
| Feb 9, 2023 | 35 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Cross-Appellant United Therapeutics Corporation. Service: 02/09/2023 by email. [903239]--[Edited 02/15/2023 by ALK - compliance review complete] This document has been corrected. See Doc No. [39]. [Jaime Santos] [Entered: 02/09/2023 02:40 PM] (107) |
| Feb 9, 2023 | 34 | Notice of Correction to Doc No. [29] for Cross-Appellant United Therapeutics Corporation. Service: 02/09/2023 by email. [903236] [22-2217] [Jaime Santos] [Entered: 02/09/2023 02:37 PM] (3) |
| Feb 6, 2023 | 33 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Liquidia Technologies, Inc.. Service: 02/06/2023 by email. [902182] [22-2217] [Sanya Sukduang] [Entered: 02/06/2023 02:52 PM] (21) |
| Feb 1, 2023 | 32 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Appellant Liquidia Technologies, Inc. Service: 02/01/2023 by email. [901327] --[Edited 02/07/2023 by ALK - compliance review complete] [Sanya Sukduang] [Entered: 02/01/2023 03:00 PM] (70) |
| Jan 27, 2023 | 31 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Liquidia Technologies, Inc., Reply Brief [30], is not in compliance with the rules of this court (see attached). Compliant document due on 02/03/2023. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [900236] [ALK] [Entered: 01/27/2023 01:51 PM] (1) |
| Jan 23, 2023 | 30 | REPLY BRIEF FILED by Cross-Appellant United Therapeutics Corporation. Service: 01/23/2023 by email. [898699] [22-2217] This document is non-compliant. See Doc No. [31]. [Sanya Sukduang] [Entered: 01/23/2023 02:51 PM] (71) |
| Dec 14, 2022 | 29 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Cross-Appellant United Therapeutics Corporation. Service: 12/14/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [890756] --[Edited 12/21/2022 by ALK - compliance review complete] This document has been corrected. See Doc No. [35]. [Jaime Santos] [Entered: 12/14/2022 07:21 PM] (107) |
| Dec 14, 2022 | 28 | Amended Certificate of Interest for Cross-Appellant United Therapeutics Corporation. Service: 12/14/2022 by email. [890750] [22-2217] [Jaime Santos] [Entered: 12/14/2022 06:51 PM] (4) |
| Nov 16, 2022 | 27 | ORDER granting motion to extend time to file brief [24] filed by Cross-Appellant United Therapeutics Corporation. The brief is due 12/14/2022. Service as of this date by the Clerk of Court. [884484] [NL] [Entered: 11/16/2022 02:39 PM] (2) |
| Nov 2, 2022 | 26 | REPLY of Cross-Appellant United Therapeutics Corporation to response [25]. Service: 11/02/2022 by email. [881681] [22-2217] [Jaime Santos] [Entered: 11/02/2022 11:43 AM] (14) |
| Nov 1, 2022 | 25 | MODIFIED ENTRY: RESPONSE of Appellant Liquidia Technologies, Inc. to Doc No. [24]. Service: 11/01/2022 by email. [881445]--[Edited 11/02/2022 by JCA - Reason: to correct filing event] [Sanya Sukduang] [Entered: 11/01/2022 11:21 AM] (12) |
| Oct 31, 2022 | 24 | MOTION of Cross-Appellant United Therapeutics Corporation to extend the time to 12/14/2022 to file brief. Service: 10/31/2022 by email. [881345] [22-2217] [Jaime Santos] [Entered: 10/31/2022 05:51 PM] (10) |
| Oct 31, 2022 | 23 | Amended Certificate of Interest for Cross-Appellant United Therapeutics Corporation. Service: 10/31/2022 by email. [881344] [22-2217] [Jaime Santos] [Entered: 10/31/2022 05:46 PM] (4) |
| Oct 27, 2022 | 22 | Entry of appearance for Rohiniyurie Tashima as counsel for Cross-Appellant United Therapeutics Corporation. Service: 10/27/2022 by email. [880588] [22-2217] [Rohiniyurie Tashima] [Entered: 10/27/2022 10:16 AM] (1) |
| Oct 21, 2022 | 21 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Liquidia Technologies, Inc. Service: 10/21/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [879588] --[Edited 10/28/2022 by ALK - compliance review complete] [Sanya Sukduang] [Entered: 10/21/2022 04:38 PM] (183) |
| Oct 21, 2022 | 20 | Amended Certificate of Interest for Appellant Liquidia Technologies, Inc.. Service: 10/21/2022 by email. [879586] [22-2217] [Sanya Sukduang] [Entered: 10/21/2022 04:37 PM] (3) |
| Oct 14, 2022 | 19 | Entry of appearance for Jenny J. Zhang as counsel for Cross-Appellant United Therapeutics Corporation. Service: 10/14/2022 by email. [878037] [22-2217] [Jenny Zhang] [Entered: 10/14/2022 03:17 PM] (1) |
| Oct 12, 2022 | 18 | ORDER filed denying the motions [874257-2] [7] filed by Liquidia Technologies, Inc. Service as of this date by the Clerk of Court. [877254] [22-2133, 22-2217] [LMS] [Entered: 10/12/2022 01:21 PM] (2) |
| Oct 11, 2022 | 17 | Note to File: The following cases are associated: 22-2217 (Lead) with 23-1021 (Cross-Appeal). The parties must file all documents in the lead appeal only. [876961] [22-2217, 23-1021] [ALK] [Entered: 10/11/2022 01:43 PM] (0) |
| Oct 11, 2022 | 16 | Official caption revised to reflect cross-appeal with 23-1021. (see attached). Service as of this date by the Clerk of Court. [876957] [ALK] [Entered: 10/11/2022 01:39 PM] (2) |
| Oct 6, 2022 | 15 | REPLY of Appellant Liquidia Technologies, Inc. to response [14]. Service: 10/06/2022 by email. [876421] [22-2217] [Sanya Sukduang] [Entered: 10/06/2022 03:41 PM] (322) |
| Oct 4, 2022 | 14 | RESPONSE of Appellee United Therapeutics Corporation to Doc No. [7], [7]. Service: 10/04/2022 by email. [875933] [22-2217] [Jaime Santos] [Entered: 10/04/2022 07:48 PM] (19) |
| Sep 30, 2022 | 13 | Entry of appearance for Jaime A. Santos; William Jackson; William M. Jay; Gerard J. Cedrone; Douglas H. Carsten; Shaun R. Snader; Arthur P. Dykhuis; Adam Burrowbridge as counsel for Appellee United Therapeutics Corporation. Service: 09/30/2022 by email. [874945] [22-2217] [Jaime Santos] [Entered: 09/30/2022 09:08 AM] (2) |
| Sep 29, 2022 | 12 | NOTICE OF NON-COMPLIANCE: The submission of Appellee United Therapeutics Corporation, Entry of Appearance [8], is not in compliance with the rules of this court (see attached). Compliant document due on 10/06/2022. Service as of this date by the Clerk of Court. [874876] [ALK] [Entered: 09/29/2022 04:50 PM] (1) |
| Sep 29, 2022 | 11 | ORDER directing United Therapeutics to respond to the motions [874257-2] [7] no later than October 4, 2022. Any reply in support of the motions is due no later than three days thereafter. Service as of this date by the Clerk of Court. [874736] [22-2133, 22-2217] [LMS] [Entered: 09/29/2022 12:52 PM] (2) |
| Sep 28, 2022 | 10 | Docketing Statement for the Appellee United Therapeutics Corporation. Service: 09/28/2022 by email. [874446] [22-2217] [Jaime Santos] [Entered: 09/28/2022 02:02 PM] (2) |
| Sep 28, 2022 | 9 | Certificate of Interest for Appellee United Therapeutics Corporation. Service: 09/28/2022 by email. [874445] [22-2217] [Jaime Santos] [Entered: 09/28/2022 02:00 PM] (3) |
| Sep 28, 2022 | 8 | Entry of appearance for Jaime A. Santos; William Jackson; William M. Jay; Gerard J. Cedrone; Douglas H. Carsten; Shaun R. Snader; Arthur P. Dykhuis; Adam Burrowbridge as counsel for Appellee United Therapeutics Corporation. Service: 09/28/2022 by email. [874444] [22-2217] This document is non-compliant. See Doc No. [12]. [Jaime Santos] [Entered: 09/28/2022 01:59 PM] (2) |
| Sep 27, 2022 | 7 | MOTION of Appellant Liquidia Technologies, Inc. to expedite briefing schedule, to expedite.. Service: 09/27/2022 by email. [874263] [22-2217] [Sanya Sukduang] [Entered: 09/27/2022 04:21 PM] (253) |
| Sep 27, 2022 | 6 | Entry of appearance for Sanya Sukduang; Jonathan R. Davies; Deepa Kannappan; Erik B. Milch as counsel for Appellant Liquidia Technologies, Inc.. Service: 09/27/2022 by email. [874261] [22-2217] [Sanya Sukduang] [Entered: 09/27/2022 04:20 PM] (2) |
| Sep 27, 2022 | 5 | Docketing Statement for the Appellant Liquidia Technologies, Inc.. Service: 09/27/2022 by email. [874259] [22-2217] [Sanya Sukduang] [Entered: 09/27/2022 04:18 PM] (2) |
| Sep 27, 2022 | 4 | Certificate of Interest for Appellant Liquidia Technologies, Inc.. Service: 09/27/2022 by email. [874258] [22-2217] [Sanya Sukduang] [Entered: 09/27/2022 04:17 PM] (3) |
| Sep 26, 2022 | 3 | Transcript Purchase Order Form for the Appellant Liquidia Technologies, Inc. indicating that a request is made to the reporter for a transcript. Service: 09/26/2022 by email. [874035] [22-2217] [Sanya Sukduang] [Entered: 09/26/2022 05:52 PM] (1) |
| Sep 19, 2022 | 2 | Note to File: The following cases shall be considered companion cases and assigned to the same merits panel: 22-2133 and 22-2217. [872439] [22-2133, 22-2217] [MMA] [Entered: 09/19/2022 09:22 AM] (0) |
| Sep 16, 2022 | 1 | Appeal docketed. Received: 09/12/2022. [872129]Entry of Appearance due 09/30/2022. Certificate of Interest is due on 09/30/2022. Docketing Statement due 09/30/2022. Appellant/Petitioner's brief is due 11/15/2022. [MMA] [Entered: 09/16/2022 07:53 AM] (103) |
